Tuberculosis in Medical Technology

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... Patients must be evaluated for the risk of tuberculosis (TB), including latent tuberculosis, prior to ... considered for the following: treatment of latent tuberculosis infection should be initiated prior to therapy ... several or highly significant risk factors for tuberculosis infection and have a negative test for latent ...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... There were no deaths, malignancies or reports of tuberculosis during the study extension. For more ... that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections ... ever had any of the following: tuberculosis (TB) or have been near someone who has TB. ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... reactions of Cimzia(R) were infections (including tuberculosis and histoplasmosis) and malignancies including ... of latent tuberculosis. Patients with tuberculosis have frequently presented with disseminated or ... disease. Patients should be tested for latent tuberculosis before CIMZIA use and during therapy. Treatment ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

... activity of the microorganisms that cause tuberculosis and toxoplasmosis, as well as a relative of ... their macrophages showed superior resistance to tuberculosis and toxoplasmosis. "Our findings reveal that ... said. Such drugs might suppress such diseases as tuberculosis and toxoplasmosis by increasing the ability of ...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

... for full prescribing information for CIMZIA. tuberculosis (frequently disseminated or extrapulmonary at ... treatment of patients with latent tuberculosis infection reduces the risk of reactivation in ... was negative. Evaluate patients for tuberculosis risk factors and test for ...

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients

... please visit http://www.ucb-group.com . tuberculosis (frequently disseminated or extrapulmonary at ... treatment of patients with latent tuberculosis infection reduces the risk of reactivation in ... was negative. Evaluate patients for tuberculosis risk factors and test for ...

CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients

... please visit http://www.ucb-group.com . tuberculosis (frequently disseminated or extrapulmonary at ... treatment of patients with latent tuberculosis infection reduces the risk of reactivation in ... was negative. Evaluate patients for tuberculosis risk factors and test for ...

Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease

... . IMPORTANT SAFETY INFORMATION tuberculosis (frequently disseminated or extrapulmonary at ... treatment of patients with latent tuberculosis infection reduces the risk of reactivation ... TNF blockers such as Cimzia(R). However, active tuberculosis has developed in patients receiving Cimzia(R) ...

Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center

... the Bill & Melinda Gates Foundation. tuberculosis currently affects nearly one-third of the ... According to the World Health Organization, tuberculosis is one of the most serious infectious diseases in ... College of Medicine and a consortium of leading tuberculosis researchers at Washington University and Stanford ...

Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa

... TB Vaccine Foundation and the South African tuberculosis Vaccine Initiative (SATVI) present a progress update and immunology data from a Phase I Ad35 tuberculosis vaccine study at the biennial "Tuberculosis ... for new TB vaccines." About Tuberculosis tuberculosis is the world's second deadliest infectious ...

Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control

... tuberculin skin test (TST) at predicting which tuberculosis (TB)-exposed individuals will go on to develop ... Director of the New Jersey Medical School Global tuberculosis Institute in Newark, New Jersey USA comments: ... reducing the overall number of cases of tuberculosis disease. For example, in the Hamburg study alone, ...

Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum

... Awareness and Funds to Fight Aids, tuberculosis and Malaria SEATTLE, Nov. 28 ... Friends of the Global Fight Against AIDS, tuberculosis and Malaria, a DC-based advocacy organization ... to Friends of the Global Fight Against AIDS, tuberculosis and Malaria, but has created a dialogue of ...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

... http://www.joinred.com/ About The Global Fund to Fight AIDS, tuberculosis and Malaria Since its creation in 2002, the Global Fund has become the dominant financer of programs to fight AIDS, tuberculosis and malaria, with approved funding of US $15 billion for programs in 140 ...

Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System

... (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis (MTB). Future GeneXpert-based tests, which apply the ten-color ... test will enable us to develop an assay for MDR and XDR Mycobacterium tuberculosis that will give clinicians a full panel of information, including ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... 11 percent of patients receiving SIMPONI. There was one case of pulmonary tuberculosis in a patient (SIMPONI 100 mg). Malignancies reported through week 104 ... fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your ...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

... System) vaccine technology with specificity for particular Mycobacterium tuberculosis (TB) antigens can elicit immune responses that would be protective against tuberculosis and have the potential to treat swine and other H1N1 influenzas. ...

Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin

... access to a rapid test that can simultaneously identify Mycobacterium tuberculosis (MTB) and resistance to rifampicin (RIF), a common first-line drug for ... of drug-resistant strains, the need for accurate and rapid detection of tuberculosis is becoming increasingly acute," said John Bishop, Cepheid's Chief ...

American Lung Association Celebrates 101st Annual Christmas Seals Campaign

... Americans alive today have no vivid memories of how widespread deadly tuberculosis was before the 1950s, but it claimed entire families and struck down ... President and CEO of the American Lung Association. In 1907, tuberculosis sanatoriums were springing up around the country, but most were makeshift ...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

... for complete information. Serious infections, sepsis, rare cases of tuberculosis (TB), and opportunistic infections, including fatalities, have been ... infections such as sepsis and opportunistic infections. If latent tuberculosis is diagnosed, appropriate treatment for latent tuberculosis must be ...

National Healthcare for Homeless Day: August 13th, 2008

... FRANCISCO, Aug. 12 /PRNewswire/ -- San Francisco has the highest rate of tuberculosis (TB) in the U.S., with recurrent outbreaks among the homeless and ... To address this health care crisis, St. Anthony's will offer free tuberculosis screening on Wednesday August 13th, 2008, as a part of National Health ...

(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa

... visit http://www.joinred.com . About The Global Fund to Fight AIDS, tuberculosis and Malaria Since its creation in 2002, the Global Fund has become the dominant financer of programs to fight AIDS, tuberculosis and malaria, with approved funding of US$10.8 billion for programs in 136 ...

Kronos Announces First Quarter Business Update and Financial Results

... technology. The Russian National Healthcare Institution Vladimir Regional tuberculosis Prevention and Treatment Center conducted in-patient room testing to ... "device can be used for air cleaning and disinfection in the rooms of tuberculosis prevention and treatment centers having high infection rates." ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... to fight infections. There are reports of serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor will test you for TB before starting SIMPONI(TM) and will monitor you ...

USAID Cooperates in Pandemic Preparedness Initiative

... this now will help ensure communities have access to uninterrupted care for pandemic illnesses as well as other diseases like HIV/AIDS, malaria, and tuberculosis that will continue to affect people in the event of a pandemic. This will help reduce excess mortality and mitigate a large-scale humanitarian ....

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

... biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles ...

Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds

... a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI). The company continues to research various compounds in hepatitis C, tuberculosis and HIV. "The Tibotec data being presented at HIV9 culminate an exciting three months for the company and for the entire HIV community," said ...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... REMICADE patients may require as few as six treatments each year. Important Safety Information There are reports of serious infections, including tuberculosis (TB), sepsis and pneumonia. Some of these infections have been fatal. Tell your doctor if you have had recent or past exposure to people with TB. ...

Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine

... a partnered S. aureus vaccine in Phase II, a therapeutic vaccine against Hepatitis C in Phase II, a Pseudomonas vaccine in Phase II, a partnered tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development. Intercell is listed on the Prime Market of the ...

Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis

... of patients in Groups 1-4, respectively. Anti-TNF therapies have been associated with serious and sometimes fatal risks, including the risk of tuberculosis and other serious infections, malignancies, heart failure, central nervous system disorders, reactivation of hepatitis B, and other serious events. ...

Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission

... (e.g. 6-mercaptopurine and azathioprine) may be continued during treatment with HUMIRA. Important Safety Information Serious infections, sepsis, tuberculosis (TB) and opportunistic infections, including fatalities, have been reported with the use of TNF-blocking agents, including HUMIRA. Many of these ...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

... REMICADE patients may require as few as six treatments each year. Important Safety Information There are reports of serious infections, including tuberculosis (TB), sepsis and pneumonia. Some of these infections have been fatal. Tell your doctor if you have had recent or past exposure to people with TB. ...

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation

... a partnered S. aureus vaccine in Phase II, a therapeutic vaccine against Hepatitis C in Phase II, a Pseudomonas vaccine in Phase II, a partnered tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development. Intercell is listed on the Prime Market of the ...

The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)

... activities and events. "We believe that early vaccination is the best defense against many vaccine-preventable diseases, such as measles, tuberculosis and rubella," says Sharon Allison-Ottey, M.D., executive director, The COSHAR Foundation. "We urge patients and caregivers to contact their ...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

... REMICADE patients may require as few as six treatments each year. Important Safety Information There are reports of serious infections, including tuberculosis (TB), sepsis and pneumonia. Some of these infections have been fatal. Tell your doctor if you have had recent or past exposure to people with TB. ...

Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis

... may include topical agents, phototherapy or medication taken by pill or injection. Important Safety Information Serious infections, sepsis, tuberculosis (TB) and opportunistic infections, including fatalities, have been reported with the use of TNF-blocking agents, including HUMIRA. Many of these ...

Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood

... percent), effective follow-up (100 percent), drug availability (100 percent), affordability (100 percent), and concern for reactivation of latent tuberculosis (50 percent), carcinogenesis (100 percent), and teratogenicity (associated with birth defects) (100 percent). No patient was currently on ...

On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS

... health care, nutrition, education, legal and psychosocial services. Recently, CHF International was also named as the Global Fund to Fight AIDS, tuberculosis and Malaria's (Global Fund) new Principal Recipient for HIV/AIDS prevention, treatment and care in Honduras. Over the next six years, CHF will be ...

Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)

... to let their doctor know if they have an infection that won't go away or a history of infections that keep coming back. People who have had tuberculosis (TB), a positive skin test for TB, recent close contact with someone who has had TB or develop any of the symptoms of TB (a dry cough that doesn't go ...

Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate

... to let their doctor know if they have an infection that won't go away or a history of infections that keep coming back. People who have had tuberculosis (TB), a positive skin test for TB, recent close contact with someone who has had TB or develop any of the symptoms of TB (a dry cough that doesn't go ...

Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis

... placebo. One case of prostate cancer and two cases of basal cell carcinoma were reported in golimumab-treated patients. There were no reports of tuberculosis or opportunistic infections through week 24. About Psoriatic Arthritis Psoriatic arthritis is a chronic inflammatory arthropathy manifesting with ...